MeSH term
Frequency | Condition_Probility | Alleles | 7 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Aortic Stenosis, Supravalvular/*genetics | 2 | 100.0 |
Base Sequence | 8 | 0.0 |
DNA | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Elastin/*genetics | 19 | 73.0 |
Exons | 4 | 0.0 |
Female | 19 | 0.0 |
Gene Frequency | 2 | 0.0 |
Humans | 37 | 0.0 |
Male | 20 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Pedigree | 12 | 0.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Elastin/genetics | 5 | 38.0 |
Phenotype | 7 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Chromosomes, Human, Pair 7/*genetics | 3 | 2.0 |
Heterozygote | 3 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Linkage Disequilibrium/genetics | 2 | 1.0 |
Middle Aged | 3 | 0.0 |
Nuclear Family | 2 | 0.0 |
DNA/analysis | 2 | 0.0 |
Polymorphism, Genetic | 7 | 0.0 |
Animals | 6 | 0.0 |
Mice | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Adolescent | 5 | 0.0 |
Adult | 8 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 7 | 0.0 |
Infant | 7 | 0.0 |
Comparative Study | 3 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
*Point Mutation | 2 | 0.0 |
Tropoelastin/*genetics | 2 | 66.0 |
*Gene Deletion | 4 | 0.0 |
Cattle | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Papio/genetics | 2 | 25.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Infant, Newborn | 3 | 0.0 |
RNA Splicing | 2 | 0.0 |
Chromosome Banding | 2 | 0.0 |
*Chromosomes, Human, Pair 7 | 11 | 3.0 |
Genetic Markers | 5 | 0.0 |
Karyotyping | 2 | 0.0 |
*Sequence Deletion | 2 | 0.0 |
Williams Syndrome/*genetics | 5 | 15.0 |
Aortic Valve Stenosis/*genetics | 3 | 75.0 |
Chromosomes, Human, Pair 7 | 3 | 1.0 |
Growth Disorders/*genetics | 2 | 3.0 |
In Situ Hybridization, Fluorescence | 7 | 0.0 |
*Mutation | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
*Chromosome Deletion | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Genotype | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Abnormalities, Multiple/diagnosis/*genetics | 2 | 16.0 |
Syndrome | 3 | 0.0 |
Deoxyribonucleases, Type II Site-Specific | 2 | 0.0 |
Homozygote | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Lod Score | 2 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
